Nectar Lifesciences Ltd.(IN:NECLIFE)
₹9.980.00 (0.00%)
IN:NECLIFE
Nectar Lifesciences Ltd. financials statements
₹9.98
At close:0.00 (0.00%)
Want to see IN:NECLIFE full AI Analyst Report?
Nectar Lifesciences Ltd. (NECLIFE) Ratios
1 Followers
Nectar Lifesciences Ltd. Ratios
IN:NECLIFE's free cash flow for Q1 2027 was ₹0.00. For the 2027 fiscal year, IN:NECLIFE's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Jun 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 8.40 | 1.21 | 1.32 | 1.38 | 1.35 |
| Quick Ratio | 8.39 | 0.54 | 0.52 | 0.63 | 0.63 |
| Cash Ratio | 3.72 | 0.02 | 0.02 | 0.02 | 0.02 |
| Solvency Ratio | -6.87 | -0.05 | 0.06 | 0.03 | 0.06 |
| Operating Cash Flow Ratio | -11.58 | 0.17 | 0.23 | 0.15 | 0.09 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.32 | 0.45 | 0.25 | 0.17 |
| Net Current Asset Value | ₹ 2.14B | ₹ 1.46B | ₹ 1.62B | ₹ 1.07B | ₹ 519.21M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.28 | 0.29 | 0.34 | 0.36 |
| Debt-to-Equity Ratio | 0.00 | 0.61 | 0.59 | 0.71 | 0.79 |
| Debt-to-Capital Ratio | 0.00 | 0.38 | 0.37 | 0.41 | 0.44 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.06 | 0.12 | 0.18 | 0.21 |
| Financial Leverage Ratio | 1.07 | 2.14 | 2.05 | 2.06 | 2.20 |
| Debt Service Coverage Ratio | 0.05 | 0.04 | 0.27 | 0.19 | 0.23 |
| Interest Coverage Ratio | -0.05 | -1.19 | 4.46 | -0.05 | 1.28 |
| Debt to Market Cap | 0.00 | 1.08 | 0.82 | 2.11 | 1.59 |
| Interest Debt Per Share | 1.73 | 29.28 | 31.83 | 37.16 | 41.88 |
| Net Debt to EBITDA | 3.87 | -22.91 | 3.65 | 7.40 | 5.23 |
| Profitability Margins | |||||
| Gross Profit Margin | -2936.29% | 18.08% | 28.61% | 3.81% | 17.94% |
| EBIT Margin | -2574.17% | -5.21% | 6.41% | 2.65% | 6.23% |
| EBITDA Margin | -1439.97% | -1.47% | 10.01% | 6.53% | 9.65% |
| Operating Profit Margin | -95.11% | -5.32% | 23.10% | -0.27% | 6.09% |
| Pretax Profit Margin | -4371.00% | -9.67% | 1.08% | -2.78% | 2.04% |
| Net Profit Margin | -14568.07% | -6.81% | 0.30% | -1.59% | 1.50% |
| Continuous Operations Profit Margin | -2852.39% | -6.81% | 0.30% | -1.59% | 1.50% |
| Net Income Per EBT | 333.29% | 70.38% | 27.34% | 57.01% | 73.49% |
| EBT Per EBIT | 4595.70% | 181.81% | 4.70% | 1035.14% | 33.54% |
| Return on Assets (ROA) | -47.12% | -5.55% | 0.23% | -1.10% | 1.05% |
| Return on Equity (ROE) | -50.30% | -11.89% | 0.47% | -2.27% | 2.30% |
| Return on Capital Employed (ROCE) | -0.32% | -8.66% | 31.94% | -0.32% | 7.33% |
| Return on Invested Capital (ROIC) | -0.21% | -4.04% | 6.21% | -0.13% | 3.82% |
| Return on Tangible Assets | -47.20% | -5.71% | 0.23% | -1.13% | 1.07% |
| Earnings Yield | -156.72% | -21.05% | 0.64% | -6.76% | 4.64% |
| Efficiency Ratios | |||||
| Receivables Turnover | 22.02 | 4.82 | 3.99 | 5.45 | 3.24 |
| Payables Turnover | 0.00 | 3.12 | 2.86 | 4.60 | 3.64 |
| Inventory Turnover | 204.71 | 1.98 | 1.55 | 2.18 | 1.90 |
| Fixed Asset Turnover | 0.02 | 2.64 | 2.57 | 2.21 | 2.18 |
| Asset Turnover | 0.00 | 0.82 | 0.77 | 0.70 | 0.70 |
| Working Capital Turnover Ratio | 0.01 | 6.34 | 5.17 | 4.41 | 8.29 |
| Cash Conversion Cycle | 18.36 | 142.95 | 199.90 | 155.10 | 204.36 |
| Days of Sales Outstanding | 16.58 | 75.70 | 91.56 | 66.98 | 112.51 |
| Days of Inventory Outstanding | 1.78 | 184.14 | 235.75 | 167.50 | 192.23 |
| Days of Payables Outstanding | 0.00 | 116.89 | 127.41 | 79.38 | 100.39 |
| Operating Cycle | 18.36 | 259.84 | 327.31 | 234.48 | 304.74 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -17.35 | 7.56 | 9.90 | 5.96 | 4.24 |
| Free Cash Flow Per Share | -17.96 | 5.60 | 8.60 | 4.62 | 3.12 |
| Dividend Paid and CapEx Coverage Ratio | -28.41 | 3.87 | 7.64 | 4.45 | 3.80 |
| Capital Expenditure Coverage Ratio | -28.41 | 3.87 | 7.64 | 4.45 | 3.80 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.29 | 0.35 | 0.18 | 0.11 |
| Operating Cash Flow to Sales Ratio | -173.45 | 0.10 | 0.13 | 0.09 | 0.06 |
| Free Cash Flow Yield | -193.16% | 23.26% | 25.11% | 28.96% | 12.99% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.64 | -4.75 | 155.68 | -14.79 | 21.53 |
| Price-to-Sales (P/S) Ratio | 92.96 | 0.32 | 0.46 | 0.23 | 0.32 |
| Price-to-Book (P/B) Ratio | 0.32 | 0.56 | 0.73 | 0.34 | 0.50 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.52 | 4.30 | 3.98 | 3.45 | 7.70 |
| Price-to-Operating Cash Flow Ratio | -0.54 | 3.19 | 3.46 | 2.68 | 5.68 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.00 | -1.29 | 0.08 | -0.16 |
| Enterprise Value Multiple | -2.58 | -44.90 | 8.26 | 10.99 | 8.58 |
| Enterprise Value | 747.57M | 11.03B | 13.93B | 10.94B | 13.81B |
| EV to EBITDA | -2.58 | -44.90 | 8.26 | 10.99 | 8.58 |
| EV to Sales | 37.18 | 0.66 | 0.83 | 0.72 | 0.83 |
| EV to Free Cash Flow | -0.21 | 8.78 | 7.14 | 10.56 | 19.73 |
| EV to Operating Cash Flow | -0.21 | 6.51 | 6.20 | 8.19 | 14.54 |
| Tangible Book Value Per Share | 28.92 | 40.12 | 44.79 | 45.27 | 46.59 |
| Shareholders’ Equity Per Share | 28.98 | 42.64 | 47.09 | 47.47 | 48.51 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.35 | 0.30 | 0.73 | 0.43 | 0.27 |
| Revenue Per Share | 0.10 | 74.48 | 74.17 | 67.94 | 74.41 |
| Net Income Per Share | -14.57 | -5.07 | 0.22 | -1.08 | 1.12 |
| Tax Burden | 3.33 | 0.70 | 0.27 | 0.57 | 0.73 |
| Interest Burden | 1.70 | 1.86 | 0.17 | -1.05 | 0.33 |
| Research & Development to Revenue | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 1.23 | 0.04 | 0.01 | 0.01 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.44 | -1.05 | 44.98 | -3.15 | 2.79 |
Currency in INR

